Targeting BRCA Deficiency in Breast Cancer: What Are the Clinical Evidences and the Next Perspectives?

Cancers - Switzerland
doi 10.3390/cancers10120506
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Targeting the Cell Cycle in Breast Cancer: Towards the Next Phase.

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2018English

Clinical and Molecular Characterization of BRCA-associated Breast Cancer: Results From the DBCG

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2017English

Phase 1 Trial of Olaparib and Oral Cyclophosphamide in BRCA Breast Cancer, Recurrent BRCA Ovarian Cancer, Non-Brca Triple-Negative Breast Cancer, and Non-Brca Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Utilization of Breast Cancer Screening in Kenya: What Are the Determinants?

BMC Health Services Research
Health Policy
2020English

Progress in Nonviral Gene Therapy for Breast Cancer and What Comes Next?

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2017English

BRCA Mutations in Women With Inflammatory Breast Cancer

Cancer
Cancer ResearchOncology
2017English

Seventeen Years After BRCA1: What Is the BRCA Mutation Status of the Breast Cancer Patients in Africa? – A Systematic Review

SpringerPlus
Multidisciplinary
2012English

Breast Cancer Brain Metastases: Biology and New Clinical Perspectives

Breast Cancer Research
Cancer ResearchOncology
2016English

Correction: Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy